See also this year's filing and all EDGAR filings for this company.
PDF Report 0001579428_2023_Axsome_Therapeutics_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001579428, Axsome Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 245,641,409 |
1 | IntangibleAssetsNetIncludingGoodwill | 69,970,772 |
2 | PropertyPlantAndEquipmentNet | 722,515 |
3 | remainder_Assets | 15,141,399 |
4 | LiabilitiesCurrent | 96,560,798 |
5 | LiabilitiesNoncurrent | 94,258,888 |
6 | remainder_Liabilities | 31,100,000 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 159,253,661 |
9 | ResearchAndDevelopmentExpense | 57,947,447 |
10 | remainder_Expenses | 12,635,053 |
11 | remainder_Revenues | 50,037,106 |
12 | remainder_NetIncome | -7,334,596 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 331,476,095 |
1 | Liabilities | 221,919,686 |
2 | Expenses | 229,836,161 |
3 | Revenues | 50,037,106 |
4 | StockholdersEquity | 109,556,409 |
5 | NetIncome | -187,133,651 |
6 | ComprehensiveNetIncome | -187,133,651 |
7 | BaseVar | 420,301,822 |
8 | EconomicCapitalRatio | 0.00471 |